Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · September 03, 2023

Impact of Oral Difelikefalin on Pruritus Intensity and Expression of Pruritic and Inflammatory Biomarkers in Patients With Atopic Dermatitis

Journal of Allergy and Clinical Immunology

 

Additional Info

Journal of Allergy and Clinical Immunology
Oral difelikefalin reduces moderate to severe pruritus and expression of pruritic and inflammatory biomarkers in subjects with atopic dermatitis
J. Allergy Clin. Immunol 2023 Jul 13;[EPub Ahead of Print], E Guttman-Yassky, P Facheris, JC Da Rosa, C Rothenberg-Lausell, E Del Duca, E David, Y Estrada, Y Liu, S Bose, M Chowdhury, C Munera, J Goncalves, K Nograles, BS Kim, M Lebwohl

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading